To access this element change to forms mode OFF
Grant Award View - GA65979
Probing Epigenetic Clonal Evolution in Acute Myeloid Leukaemia.
GA ID:
GA65979
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
12-Nov-2019
Publish Date:
16-Dec-2019
Category:
Health and Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2022
Value (AUD):
$546,800.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Ideas
Grant Activity:
Probing Epigenetic Clonal Evolution in Acute Myeloid Leukaemia.
Purpose:
Acute myeloid leukaemia (AML) is a devastating blood cancer that claims about 450 lives in Australia each year. Many patients initially do well on chemotherapy, but AML often returns with new genetic abnormalities, making it difficult to cure. To treat AML effectively, we need to know how it evolves over time. This project will test whether AML evolution can be influenced by epigenetic modifications – chemical changes to DNA that alter how genes are used without changing the genetic sequence.
GO ID:
GO Title:
Ideas Grants 2019
Internal Reference ID:
GNT1180782
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Newcastle
Recipient ABN:
15 736 576 735
Grant Recipient Location
Suburb:
Callaghan
Town/City:
Callaghan
Postcode:
2308
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA